Abbott Laboratories Financial Statements — ABT Stock

Income Statement	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Sales/Revenue/Turnover	35,167	21,407	19,050	19,657	20,247	20,405	20,853	27,390	30,578	31,904	34,608	43,075	43,653	40,109	41,950
- Cost of Revenue	14,665	10,017	8,899	9,193	9,218	8,747	9,094	12,409	12,706	13,231	15,003	18,537	19,142	17,975	18,706
+ Cost of Goods & Services	14,665	10,017	8,899	9,193	9,218	8,747	9,094	12,409	12,706	13,231	15,003	18,537	19,142	17,975	18,706
+ Sales & Services Revenue	35,167	21,407	19,050	19,657	20,247	20,405	20,853	27,390	30,578	31,904	34,608	43,075	43,653	40,109	41,950
Gross Profit	20,502	11,390	10,151	10,464	11,029	11,658	11,759	14,981	17,872	18,673	19,605	24,538	24,511	22,134	23,244
- Operating Expenses	14,101	9,761	8,791	8,331	8,430	8,791	8,733	13,417	14,222	14,141	14,248	16,113	16,149	15,656	16,419
+ Research & Development	3,724	1,512	1,461	1,371	1,345	1,405	1,447	2,260	2,300	2,440	2,420	2,742	2,888	2,741	2,844
+ Other Operating Expense	- -	884	595	588	555	601	550	1,975	2,178	1,936	2,132	2,047	2,013	1,966	1,878
+ Selling, General & Admin	10,376	7,365	6,735	6,372	6,530	6,785	6,736	9,182	9,744	9,765	9,696	11,324	11,248	10,949	11,697
+ Other Operating Income	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Income (Loss)	6,401	1,629	1,360	2,133	2,599	2,867	3,026	1,564	3,650	4,532	5,357	8,425	8,362	6,478	6,825
- Non-Operating (Income) Loss	688	393	1,580	92	81	-316	1,613	-667	777	455	389	214	56	-186	-188
+ Interest Expense, Net	448	294	261	78	73	58	332	780	721	576	500	490	375	252	215
+ Interest Expense	553	359	320	145	150	163	431	904	826	670	546	533	558	637	559
- Interest Income	105	65	59	67	77	105	99	124	105	94	46	43	183	385	344
+ Other Non-Op (Income) Loss	240	99	1,319	14	8	-374	1,281	-1,447	56	-121	-111	-276	-319	-438	-403
Pretax Income	5,713	1,236	-220	2,041	2,518	3,183	1,413	2,231	2,873	4,077	4,968	8,211	8,306	6,664	7,013
- (Income) Loss from Affiliates	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
- Income Tax Expense (Benefit)	1,087	110	-457	53	797	577	350	1,878	539	390	497	1,140	1,373	941	-6,389
Income (Loss) from Cont Ops	4,626	1,126	237	1,988	1,721	2,606	1,063	353	2,334	3,687	4,471	7,071	6,933	5,723	13,402
- Net Extraordinary Losses (Gains)	- -	-3,602	-5,726	-588	-563	-1,817	-337	-124	-34	- -	-24	- -	- -	- -	- -
+ Discontinued Operations	- -	3,602	5,726	588	563	1,817	337	124	34	- -	24	- -	- -	- -	- -
+ Extraord. & Accounting Changes	- -	-7,204	-11,452	-1,176	-1,126	-3,634	-674	-248	-68	- -	-48	- -	- -	- -	- -
Income (Loss) Incl. MI	4,626	4,728	5,963	2,576	2,284	4,423	1,400	477	2,368	3,687	4,495	7,071	6,933	5,723	13,402
- Minority Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income, GAAP	4,626	4,728	5,963	2,576	2,284	4,423	1,400	477	2,368	3,687	4,495	7,071	6,933	5,723	13,402
- Other Adjustments	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
- Preferred Dividends	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income Avail to Common, GAAP	4,626	4,728	5,963	2,576	2,284	4,423	1,400	477	2,368	3,687	4,495	7,071	6,933	5,723	13,402
Basic Weighted Avg Shares	1,547	1,570	1,577	1,548	1,508	1,473	1,473	1,744	1,756	1,763	1,771	1,764	1,738	1,734	1,732
Basic EPS, GAAP	2.99	3.01	3.78	1.66	1.51	3	0.95	0.27	1.35	2.09	2.54	4.01	3.99	3.3	7.74
Basic EPS from Cont Ops	2.99	0.72	0.15	1.28	1.14	1.77	0.72	0.2	1.33	2.09	2.52	4.01	3.99	3.3	7.74
Diluted Weighted Avg Shares	1,556	1,570	1,592	1,574	1,527	1,506	1,483	1,749	1,770	1,781	1,786	1,789	1,764	1,749	1,748
Diluted EPS, GAAP	2.97	3.01	3.75	1.64	1.5	2.94	0.94	0.27	1.34	2.07	2.52	3.95	3.93	3.27	7.67
Diluted EPS from Cont Ops	2.97	0.72	0.15	1.26	1.13	1.73	0.72	0.2	1.32	2.07	2.5	3.95	3.93	3.27	7.67
EBITDA	9,025	4,673	4,142	3,852	4,147	4,339	4,379	4,585	6,928	7,546	8,684	11,963	11,629	9,721	10,043
EBITDA Margin (%)	25.66	21.83	21.74	19.6	20.48	21.26	21	16.74	22.66	23.65	25.09	27.77	26.64	24.24	23.94
EBITA	6,401	1,629	1,360	2,133	2,599	2,867	3,026	1,564	3,650	4,532	5,357	8,425	8,362	6,478	6,825
EBIT	6,401	1,629	1,360	2,133	2,599	2,867	3,026	1,564	3,650	4,532	5,357	8,425	8,362	6,478	6,825
Gross Margin (%)	58.3	53.21	53.29	53.23	54.47	57.13	56.39	54.7	58.45	58.53	56.65	56.97	56.15	55.18	55.41
Operating Margin (%)	18.2	7.61	7.14	10.85	12.84	14.05	14.51	5.71	11.94	14.21	15.48	19.56	19.16	16.15	16.27
Profit Margin (%)	13.15	22.09	31.3	13.1	11.28	21.68	6.71	1.74	7.74	11.56	12.99	16.42	15.88	14.27	31.95
Sales per Employee	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dividend per Share	1.73	1.87	2.02	0.57	0.89	0.98	1.04	1.06	1.12	1.29	1.45	1.82	1.9	2.05	2.22
Depreciation Expense	2,624	3,044	2,782	1,719	1,548	1,472	1,353	3,021	3,278	3,014	3,327	3,538	3,267	3,243	3,218

Balance Sheet	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Total Current Assets	22,318	23,769	31,323	19,247	13,556	14,155	26,776	20,147	14,632	15,667	20,441	24,239	25,224	22,670	23,656
+ Accounts & Notes Receiv	8,729	9,687	9,370	5,490	5,561	5,326	5,054	6,916	6,750	7,211	8,281	8,833	8,881	8,821	9,495
+ Accounts Receivable, Net	7,184	7,684	7,613	3,986	3,586	3,418	3,248	5,249	5,182	5,425	6,414	6,487	6,218	6,565	6,925
+ Loans Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Notes Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Receivable, Net	1,545	2,003	1,757	1,504	1,975	1,908	1,806	1,667	1,568	1,786	1,867	2,346	2,663	2,256	2,570
+ Cash, Cash Equivalents & STI	5,451	8,097	15,174	8,098	4,460	6,125	18,775	9,610	4,086	4,140	7,148	10,249	10,170	7,279	7,967
+ Cash & Cash Equivalents	3,648	6,813	10,802	3,475	4,063	5,001	18,620	9,407	3,844	3,860	6,838	9,799	9,882	6,896	7,616
+ ST Investments	1,803	1,285	4,372	4,623	397	1,124	155	203	242	280	310	450	288	383	351
+ Inventories	3,189	3,284	3,793	2,693	2,643	2,599	2,434	3,601	3,796	4,316	5,012	5,157	6,173	6,570	6,194
+ Inventory Adjustments	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Finished Goods	2,059	2,221	2,346	1,866	1,807	1,744	1,624	2,339	2,407	2,784	3,030	3,081	3,805	3,946	3,700
+ Work In Process	384	432	629	349	278	316	294	472	499	560	712	694	680	807	840
+ Raw Materials	746	631	818	478	558	539	516	790	890	972	1,270	1,382	1,688	1,817	1,654
+ Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other ST Assets	4,949	2,701	2,986	2,966	892	105	513	20	- -	- -	- -	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc ST Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Noncurrent Assets	38,256	36,508	35,912	23,706	27,651	27,092	25,890	56,103	52,541	52,220	52,107	50,957	49,214	50,544	57,758
+ LT Investments & Receivables	302	378	274	119	229	4,041	2,947	883	897	883	821	816	766	799	886
+ LT Investments	302	378	274	119	229	4,041	2,947	883	897	883	821	816	766	799	886
+ LT Receivables	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Property, Plant & Equip, Net	7,971	7,874	8,063	5,905	5,935	5,730	5,705	7,607	7,563	8,038	9,029	8,959	9,162	10,154	10,658
- Accumulated Depreciation	9,403	10,143	10,866	6,965	6,697	6,653	6,661	7,658	8,143	8,761	9,764	10,405	11,050	11,779	12,082
+ Property, Plant & Equip	17,374	18,017	18,929	12,870	12,632	12,383	12,366	15,265	15,706	16,799	18,793	19,364	20,212	21,933	22,740
+ Other LT Assets	29,983	28,256	27,575	17,682	21,487	17,321	17,238	47,613	44,081	43,299	42,257	41,182	39,286	39,591	46,214
+ LT Deferred Tax Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Intangible Assets	28,082	25,695	24,362	15,507	16,265	15,200	12,222	45,493	42,196	40,220	38,528	35,970	33,253	32,494	29,755
+ Goodwill	15,930	15,705	15,774	9,772	10,067	9,638	7,683	24,020	23,254	23,195	23,744	23,231	22,799	23,679	23,108
+ Other Intangible Assets	12,152	9,990	8,588	5,735	6,198	5,562	4,539	21,473	18,942	17,025	14,784	12,739	10,454	8,815	6,647
+ Misc LT Assets	1,902	2,561	3,213	2,175	5,222	2,121	5,016	2,120	1,885	3,079	3,729	5,212	6,033	7,097	16,459
Total Assets	60,574	60,277	67,235	42,953	41,207	41,247	52,666	76,250	67,173	67,887	72,548	75,196	74,438	73,214	81,414
+ Payables & Accruals	10,868	12,105	10,889	5,948	5,350	5,683	5,090	8,198	8,805	9,385	11,687	12,351	13,238	12,761	12,657
+ Other Payables & Accruals	8,024	9,869	8,437	4,747	4,016	4,172	3,724	5,487	5,525	5,907	7,379	7,637	8,288	7,974	7,868
+ Accounts Payable	1,536	1,721	1,797	1,026	1,064	1,081	1,178	2,402	2,975	3,252	3,946	4,408	4,607	4,295	4,195
+ Interest & Dividends Payable	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Accrued Taxes	1,308	515	655	175	270	430	188	309	305	226	362	306	343	492	594
+ ST Debt	6,395	3,375	2,391	3,173	4,437	3,130	1,325	714	207	1,478	220	754	2,251	1,080	1,500
+ ST Borrowings	6,395	3,375	2,391	3,173	4,437	3,130	1,325	714	207	1,478	220	754	2,251	1,080	1,500
+ ST Finance Leases	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other ST Liabilities	- -	- -	- -	386	680	373	245	- -	- -	- -	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc ST Liabilities	- -	- -	- -	386	680	373	245	- -	- -	- -	- -	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Current Liabilities	17,262	15,480	13,280	9,507	10,467	9,186	6,660	8,912	9,012	10,863	11,907	13,105	15,489	13,841	14,157
+ LT Debt	12,524	12,040	18,085	3,388	3,393	5,871	20,681	27,210	19,359	17,416	19,429	18,252	15,465	14,548	13,521
+ LT Borrowings	12,524	12,040	18,085	3,388	3,393	5,871	20,681	27,210	19,359	16,661	18,527	17,296	14,522	13,599	12,625
+ LT Finance Leases	- -	- -	- -	- -	- -	- -	- -	- -	- -	755	902	956	943	949	896
+ Other LT Liabilities	8,023	8,231	9,057	4,791	5,708	4,864	4,608	9,030	8,080	8,307	8,209	7,815	6,579	5,998	5,835
+ Accrued Liabilities	1,112	703	710	466	872	808	356	2,006	2,056	1,546	1,406	1,392	991	568	512
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc LT Liabilities	4,486	4,227	3,476	2,507	1,961	1,815	2,098	4,855	3,984	3,944	3,684	3,685	3,804	3,466	3,443
+ Pension Liabilities	2,425	3,301	4,871	1,818	2,875	2,241	2,154	2,169	2,040	2,817	3,119	2,738	1,784	1,964	1,880
Total Noncurrent Liabilities	20,546	20,271	27,142	8,179	9,101	10,735	25,289	36,240	27,439	25,723	27,638	26,067	22,044	20,546	19,356
Total Liabilities	37,809	35,751	40,422	17,686	19,568	19,921	31,949	45,152	36,451	36,586	39,545	39,172	37,533	34,387	33,513
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Share Capital & APIC	17,489	19,634	23,510	24,096	24,766	25,468	26,054	46,412	47,024	23,853	24,145	24,470	24,709	24,869	25,153
+ Additional Paid in Capital	8,745	9,817	11,755	12,048	12,383	12,734	13,027	23,206	23,512	- -	- -	- -	- -	- -	- -
+ Common Stock	8,745	9,817	11,755	12,048	12,383	12,734	13,027	23,206	23,512	23,853	24,145	24,470	24,709	24,869	25,153
- Treasury Stock	3,917	3,687	5,591	6,844	8,678	10,622	10,791	10,225	9,962	10,147	10,042	11,822	15,229	15,981	16,844
+ Retained Earnings	19,216	20,907	24,151	21,979	22,874	25,757	25,565	23,978	24,560	25,847	27,627	31,528	35,257	37,554	47,261
+ Other Equity	-1,367	-2,597	-3,594	-2,012	-5,053	-6,658	-7,263	-6,062	-7,586	-8,465	-8,946	-8,374	-8,051	-7,839	-7,906
Equity Before Minority Interest	22,677	24,440	26,721	25,171	21,526	21,211	20,538	30,897	30,524	31,088	32,784	35,802	36,686	38,603	47,664
+ Minority/Non Controlling Interest	88	86	92	96	113	115	179	201	198	213	219	222	219	224	237
Total Equity	22,765	24,526	26,813	25,267	21,639	21,326	20,717	31,098	30,722	31,301	33,003	36,024	36,905	38,827	47,901
Total Liabilities & Equity	60,574	60,277	67,235	42,953	41,207	41,247	52,666	76,250	67,173	67,887	72,548	75,196	74,438	73,214	81,414
Shares Outstanding	1,547	1,570	1,577	1,548	1,508	1,473	1,473	1,744	1,756	1,763	1,771	1,764	1,738	1,734	1,732
Capital Leases - Total	- -	- -	- -	- -	- -	- -	- -	- -	- -	755	902	956	943	949	896
Net Debt	15,270	8,602	9,674	3,086	3,767	4,000	3,386	18,517	15,722	14,279	11,909	8,251	6,891	7,783	6,509
Net Debt to Equity	67.08	35.07	36.08	12.21	17.41	18.76	16.34	59.54	51.18	45.62	36.08	22.9	18.67	20.05	13.59
Tangible Common Equity Ratio	-16.36	-3.38	5.72	35.56	21.55	23.52	21	-46.8	-45.94	-32.24	-16.24	0.14	8.87	15.55	35.13
Current Ratio	1.29	1.54	2.36	2.02	1.3	1.54	4.02	2.26	1.62	1.44	1.72	1.85	1.63	1.64	1.67
Cash Conversion Cycle	116.31	185.91	223.44	172.79	132.29	127.03	113.17	97.25	92.44	89.92	92.22	73.17	79.52	99.11	98.69
Number of Employees	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Cash Flow Statement	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
+ Net Income	4,626	4,728	5,963	2,576	2,284	4,423	1,400	477	2,368	3,687	4,495	7,071	6,933	5,723	13,402
+ Depreciation & Amortization	2,624	3,044	2,782	1,719	1,548	1,472	1,353	3,021	3,278	3,014	3,327	3,538	3,267	3,243	3,218
+ Non-Cash Items	827	1,197	2,428	266	333	-2,773	1,963	157	802	766	971	695	900	770	1,155
+ Asset Impairment Charge	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Deferred Income Taxes	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Non-Cash Adj	440	814	1,995	4	87	-3,065	1,653	-249	325	247	425	55	215	126	482
+ Stock-Based Compensation	387	383	433	262	246	292	310	406	477	519	546	640	685	644	673
+ Chg in Non-Cash Work Cap	659	1	-1,859	-1,237	-490	-156	-1,513	1,915	-148	-1,331	-892	-771	-1,519	-2,475	-9,217
+ (Inc) Dec in Accts Receiv	-395	-670	36	-113	-195	-171	-177	-207	-190	-275	-924	-383	-68	-356	-691
+ Inc (Dec) in Accts Payable	360	388	-1,443	-1,101	-28	215	-1,351	1,764	533	-325	1,152	1,288	37	-1,345	-7,672
+ (Inc) Dec in Inventories	140	-130	-417	-154	-297	-257	-98	249	-514	-593	-493	-456	-1,413	-232	-58
+ (Inc) Dec in Prepaid Assets	553	413	-35	131	30	57	113	109	23	-138	-627	-312	-75	-542	-796
+ Inc (Dec) in Other	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-908	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash from Operating Activities	8,736	8,970	9,314	3,324	3,675	2,966	3,203	5,570	6,300	6,136	7,901	10,533	9,581	7,261	8,558
+ Change in Fixed & Intang	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Acq of Fixed & Intang	-1,015	-1,491	-1,795	-1,145	-1,077	-1,110	-1,121	-1,135	-1,394	-1,638	-2,177	-1,885	-1,777	-2,202	-2,207
+ Acq of Intangible Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Acq of Fixed Prod Assets	-1,015	-1,491	-1,795	-1,145	-1,077	-1,110	-1,121	-1,135	-1,394	-1,638	-2,177	-1,885	-1,777	-2,202	-2,207
+ Disp in Fixed & Intang	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Net Change in LT Investment	148	539	-3,062	-2,225	4,117	-821	886	-81	-58	-82	-73	-96	-33	-116	-141
+ Dec in LT Investment	954	5,649	8,936	7,839	5,624	4,112	3,709	129	73	21	10	77	152	43	28
+ Inc in LT Investment	-806	-5,110	-11,998	-10,064	-1,507	-4,933	-2,823	-210	-131	-103	-83	-173	-185	-159	-169
+ Net Cash From Acq & Div	-9,433	-273	-706	-580	-3,312	2,285	-55	-8,437	-6	-122	16	-53	48	-837	1
+ Cash for Acq of Subs	-9,433	-273	-706	-580	-3,317	-235	-80	-17,183	-54	-170	-42	-187	- -	-877	- -
+ Cash from Divestitures	- -	- -	- -	- -	5	2,520	25	8,746	48	48	58	134	48	40	1
+ Cash for JVs	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Investing Activities	-1,888	1,886	3	21	70	52	42	35	102	27	19	26	22	22	9
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash from Investing Activities	-12,188	661	-5,560	-3,929	-202	406	-248	-9,618	-1,356	-1,815	-2,215	-2,008	-1,740	-3,133	-2,338
+ Dividends Paid	-2,671	-2,938	-3,183	-882	-1,342	-1,443	-1,539	-1,849	-1,974	-2,270	-2,560	-3,202	-3,309	-3,556	-3,836
+ Net Cash From Debt	2,326	-3,977	3,629	-294	-577	2,428	14,922	-1,908	-8,424	-1,599	-52	-44	-746	-2,496	-437
+ Cash From Debt	4,000	-965	14,700	9	- -	2,485	14,934	6,742	4,009	1,842	1,281	4	7	2	223
+ Repayments of Debt	-1,674	-3,012	-11,071	-303	-577	-57	-12	-8,650	-12,433	-3,441	-1,333	-48	-753	-2,498	-660
+ Cash (Repurchase) of Equity	-867	-77	-2,364	-1,605	-2,195	-2,237	-522	-117	-238	-718	-403	-2,299	-3,795	-1,227	-1,295
+ Decrease in Capital Stock	-867	-77	-2,364	-1,605	-2,195	-2,237	-522	-117	-238	-718	-403	-2,299	-3,795	-1,227	-1,295
+ Increase in Capital Stock	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Financing Activities	125	569	2,113	-3,915	1,372	-984	-1,714	-1,407	245	298	236	51	214	188	164
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash from Financing Activities	-1,088	-6,423	195	-6,696	-2,742	-2,236	11,147	-5,281	-10,391	-4,289	-2,779	-5,494	-7,636	-7,091	-5,404
Effect of Foreign Exchange Rates	-621	-43	40	-26	-143	-198	-483	116	-116	-16	71	-70	-122	-23	-96
Net Changes in Cash	-4,540	3,208	3,949	-7,301	731	1,136	14,102	-9,329	-5,447	32	2,907	3,031	205	-2,963	816
Capital Expenditures	-1,015	-1,491	-1,795	-1,145	-1,077	-1,110	-1,121	-1,135	-1,394	-1,638	-2,177	-1,885	-1,777	-2,202	-2,207
EBITDA	9,025	4,673	4,142	3,852	4,147	4,339	4,379	4,585	6,928	7,546	8,684	11,963	11,629	9,721	10,043
EBITDA Margin (%)	25.66	21.83	21.74	19.6	20.48	21.26	21	16.74	22.66	23.65	25.09	27.77	26.64	24.24	23.94
Net Cash Paid for Acquisitions	9,433	273	706	580	3,312	-2,285	55	8,437	6	122	-16	53	-48	837	-1
Free Cash Flow	7,721	7,479	7,519	2,179	2,598	1,856	2,082	4,435	4,906	4,498	5,724	8,648	7,804	5,059	6,351
Free Cash Flow to Firm	8,169	7,806	- -	2,320	2,701	1,989	2,406	4,578	5,577	5,104	6,215	9,107	8,270	5,606	- -
Free Cash Flow to Equity	10,047	3,502	11,148	1,885	2,021	4,284	17,004	2,527	-3,518	2,899	5,672	8,604	7,058	2,563	5,914
Free Cash Flow per Basic Share	4.99	4.76	4.77	1.41	1.72	1.26	1.41	2.54	2.79	2.55	3.23	4.9	4.49	2.92	3.67
Price/Free Cash Flow	2.7	3.09	3.55	10.85	11.89	13.93	11.34	13.11	14.92	18.14	17.97	19.07	16.3	19.84	18.27
Cash Flow to Net Income	1.89	1.9	1.56	1.29	1.61	0.67	2.29	11.68	2.66	1.66	1.76	1.49	1.38	1.27	0.64

Abbott Laboratories

Income Statement

Balance Sheet

Cash Flow Statement